ORTHOPEDIATRICS CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $236.3M | $204.7M | $148.7M | $122.3M | $98.0M |
| Cost of revenue | $63.7M | $56.1M | $37.5M | $31.6M | $24.6M |
| Gross profit | $172.7M | $148.6M | $111.3M | $90.7M | $73.4M |
| Research and development | $9.1M | $11.0M | $10.9M | $8.5M | $5.5M |
| Operating expenses | $211.9M | $183.6M | $138.0M | $116.1M | $91.4M |
| Operating income | -$39.2M | -$35.0M | -$26.8M | -$25.4M | -$18.0M |
| Interest expense | $6.0M | $2.6M | $198,000 | $2.4M | — |
| Pretax income | -$39.2M | -$41.9M | -$21.3M | -$3.7M | -$17.4M |
| Income tax expense | $460,000 | -$4.1M | -$338,000 | -$4.9M | -$1.1M |
| Net income | -$39.6M | -$37.8M | -$21.0M | $1.3M | -$16.3M |
| Balance Sheet | |||||
| Cash and equivalents | $19.6M | $43.8M | $31.1M | $9.0M | $7.6M |
| Current assets | $256.4M | $237.2M | $226.5M | $226.7M | $133.6M |
| Total assets | $508.6M | $473.2M | $438.7M | $427.7M | $304.3M |
| Current liabilities | $46.2M | $34.0M | $41.7M | $30.9M | $29.7M |
| Total liabilities | $162.0M | $118.6M | $61.7M | $49.1M | $78.9M |
| Stockholders' equity | $346.6M | $354.6M | $377.0M | $378.6M | $225.4M |
| Cash Flow Statement | |||||
| Cash from operations | -$4.9M | -$27.0M | -$27.0M | -$21.8M | -$13.1M |
| Depreciation and amortization | $21.1M | $19.1M | $17.4M | $13.1M | $10.7M |
| Stock-based compensation | $17.8M | $13.5M | $10.5M | $6.7M | $5.8M |
| Capital expenditure | $11.1M | $14.3M | $16.9M | $10.0M | $8.1M |
| Free cash flow | -$16.0M | -$41.3M | -$43.9M | -$31.8M | -$21.2M |
| Impairments | $1.9M | $0 | $0 | $0 | $0 |
Shares outstanding 25.7M · Free float 73.0%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.